Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA approves Zavesca for type 1 Gaucher's disease

Aug. 5, 2003

Roche presents novel DPP-IV inhibitors in a recent patent

Aug. 5, 2003

Use of amylin agonists for reducing triglyceride levels

Aug. 4, 2003

Pfizer returns P-57 rights to Phytopharm

Aug. 4, 2003

Oxagen identifies novel diabetes gene

Aug. 4, 2003

Novel, more stable compositions of statin claimed

Aug. 1, 2003

Selective oxytocin receptor antagonists and their use reported by Japanese lab

July 31, 2003

Phosphatase inhibitors useful for diabetes claimed by Roche

July 31, 2003

Bisphosphonates: methods for treatment of bone disorders claimed

July 31, 2003

FDA approves Humatrope for short stature

July 31, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...